Comparison of Prognosis between Minimally Invasive and Abdominal Radical Hysterectomy for Patients with Early-Stage Cervical Cancer.
minimally invasive surgery
radical hysterectomy
uterine cervical cancer
Journal
Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503
Informations de publication
Date de publication:
24 03 2022
24 03 2022
Historique:
received:
11
01
2022
revised:
02
03
2022
accepted:
21
03
2022
entrez:
21
4
2022
pubmed:
22
4
2022
medline:
26
4
2022
Statut:
epublish
Résumé
Minimally invasive surgery (MIS) is performed to treat cervical cancer patients; however, a recent study showed that MIS was associated with higher recurrence and death rate compared with abdominal radical hysterectomy (ARH). In the current study, the prognosis of patients with early-stage cervical cancer who underwent MIS with vaginal closure or ARH was evaluated. One hundred and eighty-two patients underwent radical hysterectomy for cervical cancer with stage of IA2, IB1, and IIA1. MIS was performed by laparoscopy or a robot using the vaginal closure method. Disease-free survival (DFS) and overall survival (OS) were evaluated between the groups. Among the patients, 67 underwent MIS and 115 underwent ARH. The recurrence rate was 4.5% in MIS patients and 3.5% in ARH patients with a median follow-up (interquartile range) of 36 (18-60) and 78 (48-102) months, respectively. DFS and OS were not different between the groups (3y-DFS, 95.3% vs. 96.1%,
Identifiants
pubmed: 35448159
pii: curroncol29040185
doi: 10.3390/curroncol29040185
pmc: PMC9026697
doi:
Banques de données
ClinicalTrials.gov
['NCT00614211']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2272-2283Références
Cancer Manag Res. 2019 Jul 25;11:7015-7020
pubmed: 31440090
Front Oncol. 2020 Jul 24;10:1236
pubmed: 32903313
JAMA Oncol. 2020 Jul 1;6(7):1019-1027
pubmed: 32525511
N Engl J Med. 2018 Nov 15;379(20):1905-1914
pubmed: 30379613
Int J Gynecol Cancer. 2019 Jun;29(5):845-850
pubmed: 31155516
Int J Gynecol Cancer. 2020 Sep;30(9):1269-1277
pubmed: 32788262
J Minim Invasive Gynecol. 2021 Mar;28(3):544-555.e7
pubmed: 33359291
Cancer Res Treat. 2021 Jan;53(1):243-251
pubmed: 33070554
J Gynecol Oncol. 2019 May;30(3):e71
pubmed: 30887768
Medicine (Baltimore). 2018 Apr;97(16):e0410
pubmed: 29668599
Int J Clin Oncol. 2021 Feb;26(2):417-428
pubmed: 33433752
N Engl J Med. 2018 Nov 15;379(20):1895-1904
pubmed: 30380365
Eur J Cancer. 2019 Mar;109:1-11
pubmed: 30654224
J Gynecol Oncol. 2017 Mar;28(2):e13
pubmed: 27894166